All three forms of SCD that BEAM-101 is intended to treat have the “HbS” mutation in one of the HBB alleles, which is an A•T to T•A mutation that causes a Glu6Val substitution in the β-globin protein. The gene discussed is HBB; the disease is Schnyder corneal dystrophy.